Intellipharmaceutics International, Inc. (OTCQB: IPCIF) (TSX: IPCI) Surges 52% After Receiving FDA Approval for Generic Pristiq
Intellipharmaceutics International, Inc. (OTCQB: IPCIF) (TSX: IPCI) operates as a pharmaceutical company that is specialized within the research, development, and ...